Patent · US Active

Treating sexual desire disorders with flibanserin

US9782403B2 · kind B2 · utility

1Cited by
59References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 20, 2016
Grant dateOct 10, 2017
Priority date
Expiry dateSep 20, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the use of fibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.